These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17727345)

  • 1. The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman.
    Glina S; Gelbard MK; Akkus E; Jordan GH; Levine LA
    J Sex Med; 2007 Sep; 4(5):1209-13. PubMed ID: 17727345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
    Lin HC; Zhang HT; Jiang H
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):771-775. PubMed ID: 29726655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of treatment-related adverse events on efficacy of intralesional collagenase therapy for Peyronie's disease.
    Walker DT; Shahinyan RH; Amighi A; Regets KV; Mills JN; Eleswarapu SV
    Int J Impot Res; 2021 Jan; 33(1):128-130. PubMed ID: 32457499
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.
    Gelbard MK; James K; Riach P; Dorey F
    J Urol; 1993 Jan; 149(1):56-8. PubMed ID: 8417217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
    Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
    Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peyronie's disease.
    Pryor J; Akkus E; Alter G; Jordan G; Lebret T; Levine L; Mulhall J; Perovic S; Ralph D; Stackl W
    J Sex Med; 2004 Jul; 1(1):110-5. PubMed ID: 16422991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease.
    Russell S; Steers W; McVary KT
    Eur Urol; 2007 Mar; 51(3):640-7. PubMed ID: 17092631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xiaflex for Treatment of Peyronie's Disease.
    Shin D; Shah T; Sadeghi-Nejad H
    Eur Urol Focus; 2018 Apr; 4(3):302-303. PubMed ID: 30213657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
    Jordan GH
    J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the current conservative treatments for Peyronie's disease evidence-based?
    Gontero P; Frea B
    BJU Int; 2004 Jul; 94(1):3-4. PubMed ID: 15217420
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease?
    Poullis C; Shabbir M; Eardley I; Mulhall J; Minhas S
    BJU Int; 2016 Aug; 118(2):186-9. PubMed ID: 26683137
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of current nonsurgical management of Peyronie's disease.
    Levine LA
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S113-20. PubMed ID: 14551587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
    Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
    BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of erectile dysfunction in Peyronie's disease].
    Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
    Urologiia; 2001; (6):35-40. PubMed ID: 11785080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peyronie's disease and impotence.
    Pryor JP
    Acta Urol Belg; 1988; 56(2):317-21. PubMed ID: 3400537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.